{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "regularMarketChangePercent": -1.4829841, "regularMarketPrice": 0.6776, "exchange": "FRA", "shortName": "BIONANO GENOMICS DL-,0001", "longName": "Bionano Genomics, Inc.", "messageBoardId": "finmb_5900432", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketTime": 1683894446, "earningsTimestamp": 1683664200, "earningsTimestampStart": 1690973940, "earningsTimestampEnd": 1691409600, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.46, "epsForward": -0.25, "epsCurrentYear": -0.22, "priceEpsCurrentYear": -3.0800002, "sharesOutstanding": 306239008, "bookValue": 0.839, "fiftyDayAverage": 0.9512, "fiftyDayAverageChange": -0.27359998, "fiftyDayAverageChangePercent": -0.28763664, "twoHundredDayAverage": 1.755134, "twoHundredDayAverageChange": -1.077534, "twoHundredDayAverageChangePercent": -0.6139326, "marketCap": 207507552, "forwardPE": -2.7104, "priceToBook": 0.80762815, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.2 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1537768800000, "priceHint": 4, "regularMarketChange": -0.010199964, "regularMarketDayHigh": 0.7, "regularMarketDayRange": "0.6742 - 0.7", "regularMarketDayLow": 0.6742, "regularMarketVolume": 600, "regularMarketPreviousClose": 0.6878, "bid": 0.6778, "ask": 0.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 0.6742, "averageDailyVolume3Month": 1209, "averageDailyVolume10Day": 403, "fiftyTwoWeekLowChange": 0.121200025, "fiftyTwoWeekLowChangePercent": 0.21782894, "fiftyTwoWeekRange": "0.5564 - 3.75", "fiftyTwoWeekHighChange": -3.0724, "fiftyTwoWeekHighChangePercent": -0.8193067, "fiftyTwoWeekLow": 0.5564, "fiftyTwoWeekHigh": 3.75, "symbol": "2Y3.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "9540 Towne Centre Drive", "address2": "Suite 100", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "858 888 7600", "website": "https://bionano.com", "industry": "Medical Instruments & Supplies", "industryDisp": "Medical Instruments & Supplies", "sector": "Healthcare", "longBusinessSummary": "Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.", "fullTimeEmployees": 405, "companyOfficers": [{"maxAge": 1, "name": "Dr. Robert Erik Holmlin M.B.A., Ph.D.", "age": 54, "title": "Pres, CEO, Sec. & Director", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 834572, "fmt": "834.57k", "longFmt": "834,572"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 101674, "fmt": "101.67k", "longFmt": "101,674"}}, {"maxAge": 1, "name": "Mr. Mark  Oldakowski", "age": 48, "title": "Chief Operating Officer", "yearBorn": 1974, "fiscalYear": 2022, "totalPay": {"raw": 603824, "fmt": "603.82k", "longFmt": "603,824"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 55875, "fmt": "55.88k", "longFmt": "55,875"}}, {"maxAge": 1, "name": "Dr. Alka  Chaubey FACMG, Ph.D.", "age": 49, "title": "Chief Medical Officer", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": {"raw": 558829, "fmt": "558.83k", "longFmt": "558,829"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 167100, "fmt": "167.1k", "longFmt": "167,100"}}, {"maxAge": 1, "name": "Mr. Christopher P. Stewart", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1969, "fiscalYear": 2020, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mark  Adamchak CPA", "title": "VP of Accounting & Controller", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jonathan  Dixon J.D.", "age": 47, "title": "Gen. Counsel", "yearBorn": 1975, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Stanislas  Marin M.B.A., M.S.", "title": "Head of Global Sales", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Helene  Klein", "title": "Chief People Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Donna  Polizio", "title": "Global Head of Market Access", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Cory  Kreeck", "title": "Global Head of People Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 9, "boardRisk": 6, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}